Healthy(n = 10) | Asthma (no ICS)(n = 10) | Asthma (ICS)(n = 10) | |
---|---|---|---|
FEV1, forced expiratory volume in 1 second; ICS, inhaled corticosteroid; SABA, short acting β agonist; SPT, skin prick test; Feno, fraction of exhaled nitric oxide; QoL, quality of life. | |||
Lung function data at baseline (visit 1). | |||
F/M | 5/5 | 5/5 | 6/4 |
Mean (SD) age (years) | 35 (10.1) | 32 (8.6) | 31 (6.9) |
Mean (SD) FEV1 (l) | 4.1 (0.7) | 3.2 (0.6) | 3.3 (1.0) |
Mean (SD) FEV1 (% predicted) | 110 (11.6) | 90 (9.4) | 91 (14.7) |
Medication | – | SABA | Budesonide + SABA (n = 9; daily dose 400 μg n = 7, 800 μg n = 1, 1200 μg n = 1) |
Fluticasone propionate 500 μg + SABA (n = 1) | |||
Mean (SD) SPT (out of 10) | – | 3 (2.1) | 3 (2.3) |
Median (range) Feno | 11.0 (6.3–19.7)n = 9 | 25.2 (6.8–198.6)n = 8 | 17.2 (6.1–86.5)n = 9 |
Mean (SD) asthma specific QoL | – | 5.9 (0.88) | 6.0 (0.73) |